Mallinckrodt Files For Chapter 11 Bankruptcy Protection
Company Remains Committed To Generics Separation
After threatening it for some time, Mallinckrodt has initiated Chapter 11 bankruptcy proceedings, succumbing to thousands of claims over its part in the US opioid epidemic.
You may also be interested in...
H2 Pharma, which specializes in both generic and OTC liquid formulations, is looking to climb to the next level after receiving an equity investment from Ardian.
London-listed Hikma has signed a second partnership agreement with Arecor, proposing to co-develop a 505(b)(2) hybrid injectable product for the US market.
Zentiva has struck a new partnership to expand its already significant operations in Europe, this time in Greece with local firm Lavipharm.